KR20010081888A - 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 - Google Patents
상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 Download PDFInfo
- Publication number
- KR20010081888A KR20010081888A KR1020000008116A KR20000008116A KR20010081888A KR 20010081888 A KR20010081888 A KR 20010081888A KR 1020000008116 A KR1020000008116 A KR 1020000008116A KR 20000008116 A KR20000008116 A KR 20000008116A KR 20010081888 A KR20010081888 A KR 20010081888A
- Authority
- KR
- South Korea
- Prior art keywords
- egf
- carbomer
- growth factor
- epidermal growth
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
Abstract
Description
EGF | 0.5 mg |
카보머 934P | 0.1 g |
만니톨 | 5 g |
파라옥시안식향산메틸 | 0.04g |
파라옥시안식향산프로필 | 0.01g |
수산화나트륨 | 적당량 |
주사용증류수 | 적당량 |
총량 | 100 g |
EGF | 0.5 mg |
인산일수소나트륨 | 0.14 g |
염화나트륨 | 0.88 g |
20% 인산용액 | 적당량 |
총량 | 100 g |
EGF | 0.5 mg |
카르복시메틸셀룰로오즈 나트륨(CMC) | 0.5 g |
소르비톨 | 5.47 g |
파라옥시안식향산메틸 | 0.05 g |
수산화나트륨 | 적당량 |
주사용증류수 | 적당량 |
총량 | 100 g |
EGF | 5 mg |
카보머 934P | 1 g |
파라옥시안식향산메틸 | 0.2 g |
프로필렌글리콜 | 20 g |
수산화나트륨 | 적당량 |
주사용증류수 | 적당량 |
총량 | 100 g |
EGF | 5 mg |
폴록사머 407 | 15 g |
파라옥시안식향산메틸 | 0.2g |
인산일수소나트륨 | 272.18 mg |
염화나트륨 | 666.22 mg |
인산 | 적당량 |
프로필렌글리콜 | 20 g |
주사용증류수 | 적당량 |
총량 | 100 g |
시 료 | 초 기 | 4℃ | |||
2 주 | 4 주 | 8 주 | 18 주 | ||
실시예 10.1% 카보머 제제 | 100±2.5 | 99.2±3.2 | 102.0±4.3 | 103.7±1.2 | 101.6±3.5 |
실시예 210mM 인산완충액 제제 | 100±1.9 | 98.4±5.4 | 96.8±14.0 | 91.6±10.3 | 92.5±5.9 |
실시예 30.5% 카르복시메틸 셀룰로오즈 나트륨 제제 | 100±2.1 | 104.9±3.4 | 99.7±6.0 | 102.7±2.3 | 87.3±3.1 |
시 료 | 초 기 | 25℃ | |||
2 주 | 4 주 | 8 주 | 18 주 | ||
실시예 10.1% 카보머 제제 | 100±2.5 | 98.2±2.5 | 101.8±2.4 | 101.8±2.4 | 87.6±5.2 |
실시예 210mM 인산완충액 제제 | 100±1.9 | 81.6±3.6 | 88.4±6.9 | 81.3±1.7 | 72.5±3.3 |
실시예 30.5% 카르복시메틸 셀룰로오즈 나트륨 제제 | 100±2.1 | 93.5±6.5 | 88.4±0.2 | 78.5±2.7 | 48.7±9.3 |
시 료 | 초 기 | 4℃ | |||
2 주 | 4 주 | 8 주 | 18 주 | ||
실시예 210mM 인산완충액제제 | 100±1.9 | 98.4±5.4 | 96.8±14.0 | 91.6±10.3 | 92.5±5.9 |
실시예 41% 카보머 제제 | 100±1.8 | 104.5±14.2 | 102.3±2.6 | 101.2±0.8 | 100.3±2.3 |
실시예 515% 플록사머 제제 | 100±2.8 | 103.5±9.3 | 95.7±0.8 | 94.2±4.2 | 90.5±4.5 |
시 료 | 초 기 | 25℃ | |||
2 주 | 4 주 | 8 주 | 18 주 | ||
실시예 210mM 인산완충액 제제 | 100±1.9 | 81.6±3.6 | 88.4±6.9 | 81.3±1.7 | 72.5±3.3 |
실시예 41% 카보머 제제 | 100±1.8 | 107.3±2.0 | 92.5±0.5 | 101.8±2.4 | 99.5±4.5 |
실시예 515% 플록사머 제제 | 100±2.8 | 90.3±41.4 | 79.5±5.0 | 78.5±2.7 | 66.4±2.6 |
Claims (8)
- 생물학적 활성이 있는 상피세포 성장인자(EGF)를 유효성분으로 하고, 카르복시 비닐 폴리머를 기제로 포함하는 안정한 EGF 조성물.
- 제 1항에 있어서,생물학적 활성이 있는 EGF는 천연형 또는 재조합 단백질 형태로 제조된것을 특징으로 하는안정한 EGF조성물.
- 제 1항에 있어서,생물학적 활성이 있는 EGF는 전체 제제에 대하여 농도가 0.01 내지1000㎍/g인 것을 특징으로 하는안정한 EGF 조성물.
- 제 1항에 있어서,pH가 4 내지 8인 것을 특징으로 하는안정한 EGF 조성물.
- 제 1항에 있어서,카르복시 비닐 폴리머는 카보머 934, 카보머 934P, 카보머 940, 카보머941 또는 카보머 947P인 것을 특징으로 하는안정한 EGF 조성물.
- 제 1항에 있어서,카르복시 비닐 폴리머는 전체 제제에 대하여 농도가 0.001 내지 50(w/w)%인 것을 특징으로하는안정한 EGF 조성물.
- 제 1항에 있어서,외용제인 것을 특징으로 하는안정한 EGF 조성물.
- 제 1항에 있어서,점안제인 것을 특징으로 하는안정한 EGF 조성물.
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0008116A KR100366439B1 (ko) | 2000-02-21 | 2000-02-21 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
EP01904630A EP1178818A4 (en) | 2000-02-21 | 2001-02-06 | A STABLE COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR AS AN ACTIVE COMPONENT |
PCT/KR2001/000170 WO2001062276A1 (en) | 2000-02-21 | 2001-02-06 | A stable composition comprising epidermal growth factor as an active ingredient |
AU32403/01A AU3240301A (en) | 2000-02-21 | 2001-02-06 | A stable composition comprising epidermal growth factor as an active ingredient |
CN01800267A CN1362883A (zh) | 2000-02-21 | 2001-02-06 | 包含表皮生长因子作为活性成分的稳定组合物 |
JP2001561341A JP3761816B2 (ja) | 2000-02-21 | 2001-02-06 | 上皮細胞成長因子を有効成分とする安定した組成物 |
US09/958,116 US20030050238A1 (en) | 2000-02-21 | 2001-02-06 | Stable composition comprising epidermal growth factor as an active ingredient |
IDW00200102257A ID30336A (id) | 2000-02-21 | 2001-02-06 | Komposisi stabil yang mengandung faktor pertumbuhan epidermal sebagai bahan aktif |
MXPA01010566A MXPA01010566A (es) | 2000-02-21 | 2001-02-06 | Una composicion estable que comprende factor de crecimiento epidermico como un ingrediente activo. |
RU2001131354/15A RU2222344C2 (ru) | 2000-02-21 | 2001-02-06 | Стабильная композиция, включающая фактор роста эпидермиса в качестве активного ингредиента |
CA002368364A CA2368364A1 (en) | 2000-02-21 | 2001-02-06 | A stable composition comprising epidermal growth factor as an active ingredient |
BR0104587-3A BR0104587A (pt) | 2000-02-21 | 2001-02-06 | Composição estável |
HK03100035.4A HK1047712A1 (zh) | 2000-02-21 | 2003-01-03 | 包含表皮生長因子作為活性成分的穩定組合物 |
US11/113,075 US20050186280A1 (en) | 2000-02-21 | 2005-04-25 | Method for stabilizing a composition having a biologically active epidermal growth factor as an active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0008116A KR100366439B1 (ko) | 2000-02-21 | 2000-02-21 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010081888A true KR20010081888A (ko) | 2001-08-29 |
KR100366439B1 KR100366439B1 (ko) | 2003-01-09 |
Family
ID=19648192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0008116A KR100366439B1 (ko) | 2000-02-21 | 2000-02-21 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
Country Status (13)
Country | Link |
---|---|
US (2) | US20030050238A1 (ko) |
EP (1) | EP1178818A4 (ko) |
JP (1) | JP3761816B2 (ko) |
KR (1) | KR100366439B1 (ko) |
CN (1) | CN1362883A (ko) |
AU (1) | AU3240301A (ko) |
BR (1) | BR0104587A (ko) |
CA (1) | CA2368364A1 (ko) |
HK (1) | HK1047712A1 (ko) |
ID (1) | ID30336A (ko) |
MX (1) | MXPA01010566A (ko) |
RU (1) | RU2222344C2 (ko) |
WO (1) | WO2001062276A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100784134B1 (ko) * | 2006-10-09 | 2007-12-12 | 주식회사 대웅 | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 |
KR20180060701A (ko) | 2016-11-29 | 2018-06-07 | 주식회사 엔씨엘바이오 | 표피 생장 인자를 함유하는 피부 상태 개선용 조성물 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100366439B1 (ko) * | 2000-02-21 | 2003-01-09 | 주식회사 대웅 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
US7517528B2 (en) * | 2002-03-12 | 2009-04-14 | Bio-Click Technologies, Ltd. | Method and composition for treating skin wounds with epidermal growth factor |
CN101172091B (zh) * | 2007-09-25 | 2011-04-27 | 北京美福源生物医药科技有限公司 | 含人血清白蛋白与皮肤细胞生长因子的融合蛋白护肤产品制备工艺和用途 |
TW200505394A (en) * | 2003-06-06 | 2005-02-16 | Asahi Medical Co | Material promoting wound healing |
AU2006250763A1 (en) | 2005-05-27 | 2006-11-30 | Bharat Biotech International Limited | Epidermal growth factor composition, a process therefor and its application |
KR100748390B1 (ko) * | 2005-11-14 | 2007-08-10 | 주식회사 대웅 | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 |
KR100752990B1 (ko) | 2006-08-02 | 2007-08-30 | 주식회사 대웅 | 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물 |
JP5303322B2 (ja) * | 2009-03-13 | 2013-10-02 | ピアス株式会社 | 皮膚外用組成物 |
GB0916124D0 (en) | 2009-09-15 | 2009-10-28 | Univ Cardiff | Method and kit for the classification and prognosis of wounds |
GB201021182D0 (en) | 2010-12-14 | 2011-01-26 | Univ Cardiff | Methdo and kit for the classification and prognosis of chronic wounds |
GB201103898D0 (en) * | 2011-03-08 | 2011-04-20 | Univ Cardiff | Molecular targets for healing or treating wounds |
ES2502691B1 (es) * | 2013-09-25 | 2015-07-07 | Sani-Red, S.L. | Método de conservación y estabilización de proteínas, aplicable para desarrollos industriales de formulaciones de productos sanitarios, farmacéuticos y cosméticos |
CN105078784B (zh) * | 2014-04-25 | 2018-07-20 | 张文炜 | 肽类护肤品及其制备方法 |
CN104644464A (zh) * | 2015-02-06 | 2015-05-27 | 深圳唯美度生物科技有限公司 | 一种提高细胞活力的防干燥油及其制备方法 |
KR101777910B1 (ko) | 2015-04-30 | 2017-09-13 | 주식회사 제네웰 | 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ235556A (en) * | 1986-11-05 | 1991-06-25 | Ethicon Inc | Breast milk substitute containing recombinant human egf |
US4717717A (en) * | 1986-11-05 | 1988-01-05 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
IN172390B (ko) * | 1989-07-18 | 1993-07-10 | Ethicon Inc | |
JPH05132426A (ja) * | 1991-02-15 | 1993-05-28 | Takeda Chem Ind Ltd | 骨組織の形成促進剤 |
CU22405A1 (es) * | 1993-07-05 | 1996-01-31 | Cigb | Composicion cosmetica para el cuidado de la piel |
US6541447B1 (en) * | 1999-09-01 | 2003-04-01 | B & M Healthcare Technologies, Inc. | Wound healing composition and method for use thereof |
KR100377397B1 (ko) * | 1999-12-23 | 2003-03-26 | 주식회사 대웅 | 레티놀 및 표피성장인자를 함유하는 피부보호 화장료 조성물 |
KR100366439B1 (ko) * | 2000-02-21 | 2003-01-09 | 주식회사 대웅 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
-
2000
- 2000-02-21 KR KR10-2000-0008116A patent/KR100366439B1/ko active IP Right Grant
-
2001
- 2001-02-06 ID IDW00200102257A patent/ID30336A/id unknown
- 2001-02-06 BR BR0104587-3A patent/BR0104587A/pt not_active Application Discontinuation
- 2001-02-06 JP JP2001561341A patent/JP3761816B2/ja not_active Expired - Lifetime
- 2001-02-06 CA CA002368364A patent/CA2368364A1/en not_active Abandoned
- 2001-02-06 EP EP01904630A patent/EP1178818A4/en not_active Withdrawn
- 2001-02-06 WO PCT/KR2001/000170 patent/WO2001062276A1/en active Application Filing
- 2001-02-06 RU RU2001131354/15A patent/RU2222344C2/ru active
- 2001-02-06 AU AU32403/01A patent/AU3240301A/en not_active Abandoned
- 2001-02-06 CN CN01800267A patent/CN1362883A/zh active Pending
- 2001-02-06 US US09/958,116 patent/US20030050238A1/en not_active Abandoned
- 2001-02-06 MX MXPA01010566A patent/MXPA01010566A/es active IP Right Grant
-
2003
- 2003-01-03 HK HK03100035.4A patent/HK1047712A1/zh unknown
-
2005
- 2005-04-25 US US11/113,075 patent/US20050186280A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100784134B1 (ko) * | 2006-10-09 | 2007-12-12 | 주식회사 대웅 | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 |
KR20180060701A (ko) | 2016-11-29 | 2018-06-07 | 주식회사 엔씨엘바이오 | 표피 생장 인자를 함유하는 피부 상태 개선용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
HK1047712A1 (zh) | 2003-03-07 |
US20030050238A1 (en) | 2003-03-13 |
US20050186280A1 (en) | 2005-08-25 |
AU3240301A (en) | 2001-09-03 |
CN1362883A (zh) | 2002-08-07 |
EP1178818A1 (en) | 2002-02-13 |
EP1178818A4 (en) | 2009-05-13 |
RU2222344C2 (ru) | 2004-01-27 |
JP3761816B2 (ja) | 2006-03-29 |
KR100366439B1 (ko) | 2003-01-09 |
JP2003523399A (ja) | 2003-08-05 |
BR0104587A (pt) | 2002-01-08 |
CA2368364A1 (en) | 2001-08-30 |
MXPA01010566A (es) | 2002-11-04 |
WO2001062276A1 (en) | 2001-08-30 |
ID30336A (id) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100366439B1 (ko) | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 | |
JP2763815B2 (ja) | 表皮成長因子を含有する安定化された組成物 | |
KR100748390B1 (ko) | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 | |
US8241620B2 (en) | Complex polymere amphiphile-PDGF | |
EP1312366B1 (en) | Gelling aqueous pharmaceutical compositions | |
US11179443B2 (en) | Stabilized external preparation comprising thymosin beta 4 as an active ingredient | |
AU2001277767B2 (en) | Skin wound healing promoters | |
KR20140132388A (ko) | 알파 코넥신 c-말단 (act) 펩타이드를 포함하는 국소 겔 | |
EP0914827B1 (en) | Ophthalmic drug compositions | |
JP3624158B2 (ja) | ヒト上皮成長因子を含有する皮膚外用剤組成物 | |
KR960013439B1 (ko) | 안정한 상피세포 성장인자(egf) 조성물 | |
ES2297111T3 (es) | Composicion farmaceutica de clorhidrato de diltiazem estable para aplicacion cutanea y proceso para su preparacion. | |
JPH01308235A (ja) | ヒト成長ホルモン経鼻剤 | |
ES2348471T3 (es) | Promotores de cicatrización de heridas. | |
US20020182696A1 (en) | Stabilized enzyme compositions | |
KR20120139299A (ko) | 표피세포성장인자를 함유하는 안정한 주사제용 동결건조 조성물 | |
US20140287995A1 (en) | Stable pharmaceutical formulations of growth factor peptides | |
MXPA00008669A (en) | Topical composition containing human epidermal growth factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20170410 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20180404 Year of fee payment: 17 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 18 |